🚀 VC round data is live in beta, check it out!

Savaria Valuation Multiples

Discover revenue and EBITDA valuation multiples for Savaria and similar public comparables like C Sun Manufacturing, Pulse Biosciences, thyssenkrupp nucera, Vitrolife and more.

Savaria Overview

About Savaria

Savaria Corp designs, engineers, and manufactures products for personal mobility. Its products include home elevators, wheelchair lifts, commercial elevators, ceiling lifts, stairlifts, and van conversions. The company's operating segments are Accessibility and Patient Care. The Accessibility segment deals with manufacturing, designing, installing, and distributing elevators, platform lifts, and stairlifts for people with mobility challenges. The Patient Care segment includes the manufacturing and distribution of a comprehensive line of therapeutic support surfaces and other pressure management products for the medical market. It derives maximum revenue from Accessibility segment.


Founded

1999

HQ

Canada

Employees

2.4K

Financials (LTM)

Revenue: $675M
EBITDA: $139M

EV

$1B

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Savaria Financials

Savaria reported last 12-month revenue of $675M and EBITDA of $139M.

In the same LTM period, Savaria generated $260M in gross profit, $139M in EBITDA, and $55M in net income.


Savaria P&L

In the most recent fiscal year, Savaria reported revenue of $668M and EBITDA of $136M.

Savaria expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Savaria forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue$675MXXX$668MXXXXXXXXX
Gross Profit$260MXXX$255MXXXXXXXXX
Gross Margin39%XXX38%XXXXXXXXX
EBITDA$139MXXX$136MXXXXXXXXX
EBITDA Margin21%XXX20%XXXXXXXXX
EBIT Margin13%XXX13%XXXXXXXXX
Net Profit$55MXXX$50MXXXXXXXXX
Net Margin8%XXX8%XXXXXXXXX
Net Debt——$97MXXXXXXXXX

Financial data powered by Morningstar, Inc.

Savaria Stock Performance

Savaria has current market cap of $1B, and enterprise value of $1B.


Savaria's stock price is $18.13.

See Savaria trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1B$1B-0.3%XXXXXXXXX$0.70

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Savaria Valuation Multiples

Savaria trades at 2.1x EV/Revenue multiple, and 10.4x EV/EBITDA.

See valuation multiples for Savaria and 15K+ public comps

Savaria Financial Valuation Multiples

As of March 29, 2026, Savaria has market cap of $1B and EV of $1B.

Equity research analysts estimate Savaria's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Savaria has a P/E ratio of 23.5x.

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$1BXXX$1BXXXXXXXXX
EV (current)$1BXXX$1BXXXXXXXXX
EV/Revenue2.1xXXX2.2xXXXXXXXXX
EV/EBITDA10.4xXXX10.6xXXXXXXXXX
EV/EBIT16.5xXXX17.3xXXXXXXXXX
EV/Gross Profit5.6xXXX5.7xXXXXXXXXX
P/E23.5xXXX25.8xXXXXXXXXX
EV/FCF20.1xXXX17.3xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Savaria Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Savaria Margins & Growth Rates

Savaria's revenue in the last 12 month grew by 5%.

Savaria's revenue per employee in the last FY averaged $0.3M.

Savaria's rule of 40 is 25% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Savaria's rule of X is 33% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Savaria and other 15K+ public comps

Savaria Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue Growth5%XXX4%XXXXXXXXX
EBITDA Margin21%XXX20%XXXXXXXXX
EBITDA Growth8%XXX7%XXXXXXXXX
Rule of 40—XXX25%XXXXXXXXX
Bessemer Rule of X—XXX33%XXXXXXXXX
Revenue per Employee—XXX$0.3MXXXXXXXXX
G&A Expenses to Revenue—XXX26%XXXXXXXXX
Opex to Revenue—XXX26%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Savaria Public Comps

See public comps and valuation multiples for other Medical Devices and Machinery comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
C Sun ManufacturingXXXXXXXXXXXXXXXXXX
Pulse BiosciencesXXXXXXXXXXXXXXXXXX
thyssenkrupp nuceraXXXXXXXXXXXXXXXXXX
VitrolifeXXXXXXXXXXXXXXXXXX
Subgen AIXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Savaria M&A Activity

Savaria acquired XXX companies to date.

Last acquisition by Savaria was on XXXXXXXX, XXXXX. Savaria acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Savaria

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Savaria Investment Activity

Savaria invested in XXX companies to date.

Savaria made its latest investment on XXXXXXXX, XXXXX. Savaria invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Savaria

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Savaria

When was Savaria founded?Savaria was founded in 1999.
Where is Savaria headquartered?Savaria is headquartered in Canada.
How many employees does Savaria have?As of today, Savaria has over 2K employees.
Is Savaria publicly listed?Yes, Savaria is a public company listed on Tokyo Stock Exchange.
What is the stock symbol of Savaria?Savaria trades under SIS ticker.
When did Savaria go public?Savaria went public in 2003.
Who are competitors of Savaria?Savaria main competitors are C Sun Manufacturing, Pulse Biosciences, thyssenkrupp nucera, Vitrolife.
What is the current market cap of Savaria?Savaria's current market cap is $1B.
What is the current revenue of Savaria?Savaria's last 12 months revenue is $675M.
What is the current revenue growth of Savaria?Savaria revenue growth (NTM/LTM) is 5%.
What is the current EV/Revenue multiple of Savaria?Current revenue multiple of Savaria is 2.1x.
Is Savaria profitable?Yes, Savaria is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Savaria?Savaria's last 12 months EBITDA is $139M.
What is Savaria's EBITDA margin?Savaria's last 12 months EBITDA margin is 21%.
What is the current EV/EBITDA multiple of Savaria?Current EBITDA multiple of Savaria is 10.4x.
What is the current FCF of Savaria?Savaria's last 12 months FCF is $72M.
What is Savaria's FCF margin?Savaria's last 12 months FCF margin is 11%.
What is the current EV/FCF multiple of Savaria?Current FCF multiple of Savaria is 20.1x.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial